26 May 2017
(MENAFN) UAE-based Julphar Gulf Pharmaceutical Industries, a pioneering pharmaceutical producer in the MENA region has recorded sales reaching USD100.5mn in Q1 of this year.
Furthermore, the board of the firm discussed and reviewed the development of the firm’s Vision 2020.
By 2020, the firm plans to reach more than USD544.4mn sales and rank amid the major three pharmaceutical firms in the country and in Saudi Arabia.
However, despite challenging market situations and the whole regional situation that are impacting the industry, the firm is considering its market share for the cited period.
MENAFN2605201700450000ID1095512067
MENAFN2605201700450000ID1095512067
01 Mar 2026
BBK activates partial remote working system for its workforce to ensure employee and customer safety and service continuity
24 Feb 2026
BBK discloses its financial results for the year ended 31st December 2025
05 Feb 2026
BBK announces December Al Hayrat Grand Prize winners and another wave of Grand prizes for February
26 Jan 2026
BBK Enhances Autumn Fair 2026 Experience with Customized Rewards and Premium Services
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more